# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001347178-20-000013
Filing Date
2020-05-07
Accepted
2020-05-07 07:01:11
Documents
77
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vnda331202010q.htm iXBRL | 10-Q | 1110329
2 | EXHIBIT 10.42 | vndaex1042331202010q.htm | EX-10.42 | 48707
3 | EXHIBIT 31.1 | vndaex311331202010q.htm | EX-31.1 | 13579
4 | EXHIBIT 31.2 | vndaex312331202010q.htm | EX-31.2 | 13537
5 | EXHIBIT 32.1 | vndaex321331202010q.htm | EX-32.1 | 9464
| Complete submission text file | 0001347178-20-000013.txt |  | 5687057

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vnda-20200331.xsd | EX-101.SCH | 46965
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vnda-20200331_cal.xml | EX-101.CAL | 78323
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vnda-20200331_def.xml | EX-101.DEF | 195422
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vnda-20200331_lab.xml | EX-101.LAB | 570630
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vnda-20200331_pre.xml | EX-101.PRE | 352614
20 | EXTRACTED XBRL INSTANCE DOCUMENT | vnda331202010q_htm.xml | XML | 856376

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34186 | Film No.: 20854503
SIC: 2834 Pharmaceutical Preparations